Moderna shares plunge after leak of cancer vaccine data despite positive results

The Quick Take
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to CNBC.


